128 related articles for article (PubMed ID: 6171882)
1. Sensory and motor functions of spinal cord substance P.
Piercey MF; Schroeder LA; Folkers K; Xu JC; Horig J
Science; 1981 Dec; 214(4527):1361-3. PubMed ID: 6171882
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects of spinal cord substance P: studies with a stable receptor agonist.
Keeler JR; Charlton CG; Helke CJ
J Pharmacol Exp Ther; 1985 Jun; 233(3):755-60. PubMed ID: 2409270
[TBL] [Abstract][Full Text] [Related]
3. The effects of substance P analogues on the scratching, biting and licking response induced by intrathecal injection of N-methyl-D-aspartate in mice.
Sakurada T; Manome Y; Tan-No K; Sakurada S; Kisara K
Br J Pharmacol; 1990 Oct; 101(2):307-10. PubMed ID: 1701675
[TBL] [Abstract][Full Text] [Related]
4. Possible involvement of the spinal substance P system in pilocarpine-induced scratching in mice.
Sakurada T; Manome Y; Tan-No K; Matsunaga Y; Sakurada S; Kisara K
Pharmacol Biochem Behav; 1993 Feb; 44(2):439-45. PubMed ID: 7680485
[TBL] [Abstract][Full Text] [Related]
5. Substance p analogue blocks sp-induced facilitation of a spinal nociceptive reflex.
Yashpal K; Henry JL
Brain Res Bull; 1984 Oct; 13(4):597-600. PubMed ID: 6084544
[TBL] [Abstract][Full Text] [Related]
6. Interactions of substance P antagonists with serotonin in the mouse spinal cord.
Vaught JL; Scott R
Peptides; 1988; 9(4):909-13. PubMed ID: 2465543
[TBL] [Abstract][Full Text] [Related]
7. Lack of potent antinociceptive activity by substance P antagonist CP-96,345 in the rat spinal cord.
Garces YI; Rabito SF; Minshall RD; Sagen J
Life Sci; 1993; 52(4):353-60. PubMed ID: 7678436
[TBL] [Abstract][Full Text] [Related]
8. Analgesic activities of spinal cord substance P antagonists implicate substance P as a neurotransmitter of pain sensation.
Piercey MF; Moon MW; Blinn JR; Dobry-Schreur PJ
Brain Res; 1986 Oct; 385(1):74-85. PubMed ID: 2429737
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal administration of a substance P receptor antagonist: studies on peripheral and central nervous system hemodynamics and on specificity of action.
Helke CJ; Phillips ET; O'Neill JT
J Pharmacol Exp Ther; 1987 Jul; 242(1):131-6. PubMed ID: 2441024
[TBL] [Abstract][Full Text] [Related]
10. Is substance P a primary afferent neurotransmitter for nociceptive input? IV. 2-Amino-5-phosphonovalerate (APV) and [D-Pro2,D-Trp7,9]-substance P exert different effects on behaviors induced by intrathecal substance P, strychnine and kainic acid.
Bossut D; Frenk H; Mayer DJ
Brain Res; 1988 Jul; 455(2):247-53. PubMed ID: 2456842
[TBL] [Abstract][Full Text] [Related]
11. The role of substance P as a neurotransmitter in the reflexes of slow time courses in the neonatal rat spinal cord.
Akagi H; Konishi S; Otsuka M; Yanagisawa M
Br J Pharmacol; 1985 Mar; 84(3):663-73. PubMed ID: 2580581
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal oxymetazoline does not produce neurotoxicity in the spinal cord of the rat.
Loomis CW; Vyas D; Sherman SE
Brain Res; 1992 Dec; 599(1):73-82. PubMed ID: 1283563
[TBL] [Abstract][Full Text] [Related]
13. Spinally-mediated behavioural responses evoked by intrathecal high-dose morphine: possible involvement of substance P in the mouse spinal cord.
Sakurada T; Wako K; Sakurada C; Manome Y; Tan-no K; Sakurada S; Kisara K
Brain Res; 1996 Jun; 724(2):213-21. PubMed ID: 8828571
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of smooth muscle contractions induced by capsaicin and electrical transmural stimulation by a substance P antagonist.
Björkroth U
Acta Physiol Scand Suppl; 1983; 515():11-6. PubMed ID: 6194652
[No Abstract] [Full Text] [Related]
15. An antinociceptive effect of capsaicin in the adult mouse mediated by the NH2-terminus of substance P.
Mousseau DD; Sun X; Larson AA
J Pharmacol Exp Ther; 1994 Feb; 268(2):785-90. PubMed ID: 7509392
[TBL] [Abstract][Full Text] [Related]
16. [Intrathecal injection of Sar9, Met(O2)11-substance P, neurokinin-1 receptor agonist, increases nitric oxide synthase expression and nitric oxide production in the rat spinal cord].
Sun XC; Li WB; Li SQ; Li QJ; Chen XL; Ai J
Sheng Li Xue Bao; 2003 Dec; 55(6):677-83. PubMed ID: 14695485
[TBL] [Abstract][Full Text] [Related]
17. LY303870, a centrally active neurokinin-1 antagonist with a long duration of action.
Iyengar S; Hipskind PA; Gehlert DR; Schober D; Lobb KL; Nixon JA; Helton DR; Kallman MJ; Boucher S; Couture R; Li DL; Simmons RM
J Pharmacol Exp Ther; 1997 Feb; 280(2):774-85. PubMed ID: 9023291
[TBL] [Abstract][Full Text] [Related]
18. Interaction of substance P antagonists with substance P receptors on dispersed pancreatic acini.
Jensen RT; Jones SW; Lu YA; Xu JC; Folkers K; Gardner JD
Biochim Biophys Acta; 1984 Jun; 804(2):181-91. PubMed ID: 6202326
[TBL] [Abstract][Full Text] [Related]
19. Agonist effects of [D-Pro2,D-Phe7,D-Trp9]substance P--evidence for different receptors.
Hawcock AB; Hayes AG; Tyers MB
Eur J Pharmacol; 1982 May; 80(1):135-8. PubMed ID: 6178612
[TBL] [Abstract][Full Text] [Related]
20. Amino terminus of substance P potentiates kainic acid-induced activity in the mouse spinal cord.
Larson AA; Sun X
J Neurosci; 1992 Dec; 12(12):4905-10. PubMed ID: 1281498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
